In 2024, Italy leads the global stem cell transplantation market with 5.87 thousand inpatient cases, followed by France with 5.02 thousand cases, and Spain with 3.92 thousand cases. Australia exhibits significant growth, reaching 2.96 thousand cases in 2024, a notable increase from previous years. The Netherlands, Sweden, Switzerland, Israel, and the Czech Republic follow, each with fewer than 2 thousand cases.
Year-on-year variations from 2023 indicate diverse trends:
- Italy: 0.9% increase
- France: 1.27% decrease
- Spain: 3.03% increase
- Australia: 10.18% increase
- Netherlands: 3.44% increase
- Sweden: 0.76% increase
- Switzerland: 2.88% increase
- Israel: 1.76% increase
- Czech Republic: 0.25% decrease
Future trends to watch for include exponential growth in countries with current substantial increases, like Australia and Spain. Enhanced treatment efficacy, technological advancements, and increased healthcare funding are likely to drive expansion globally, particularly in underrepresented regions.
Top countries in Stem Cell Transplantation Performed by Country
| # | 9 Countries | Units (Inpatient Cases) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 5,870 | 2023 | +0.62% | +0.9% | View data |
| 2 | 2 France | 5,020 | 2023 | +0.12% | -1.27% | View data |
| 3 | 3 Spain | 3,920 | 2023 | +4.28% | +3.03% | View data |
| 4 | 4 Australia | 2,960 | 2023 | +5.57% | +10.18% | View data |
| 5 | 5 Netherlands | 1,850 | 2023 | +3.18% | +3.44% | View data |
| 6 | 6 Sweden | 896 | 2023 | +3.45% | +0.76% | View data |
| 7 | 7 Switzerland | 891 | 2023 | +3.13% | +2.88% | View data |
| 8 | 8 Israel | 780 | 2023 | +6.85% | +1.76% | View data |
| 9 | 9 Czech Republic | 720 | 2023 | -0.55% | -0.25% | View data |
